ArticleCell death & disease2022

HSPB8 counteracts tumor activity of BRAF- and NRAS-mutant melanoma cells by modulation of RAS-prenylation and autophagy.

Riccardo Cristofani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.